{"transactions":[{"id":1579312,"issuer":{"id":85616,"kind":"organization","name":"Viracta Therapeutics, Inc.","symbol":"VIRX"},"owners":[{"id":93117,"kind":"person","name":"Rothera Mark","position":1,"cik":"0001550424","reported_name":"Rothera Mark","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-03-13T20:36:16.000Z","date":"2024-03-12","kind":"grant","planned":false,"acquired":true,"shares":475000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/48th of the total shares subject to the Option will vest each month on the same day of the month as the Vesting Commencement Date (as defined below), and if there is no corresponding day, the last day of the month, subject to the Reporting Person continuing to be a Service Provider in accordance with the Company's 2021 Equity Incentive Plan through each such date. The Vesting Commencement Date is January 1, 2024."}],"balance_after":475000,"derivative":{"exercise_price":0.985,"expiration_date":"2034-03-12","underlying":"Common Stock","underlying_shares":475000},"source":{"system":"sec-edgar","filing":"0001209191-24-004829","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1061027/000120919124004829/doc4.xml","form_type":"4"}},{"id":1724332,"issuer":{"id":85616,"kind":"organization","name":"Viracta Therapeutics, Inc.","symbol":"VIRX"},"owners":[{"id":93117,"kind":"person","name":"Rothera Mark","position":1,"cik":"0001550424","reported_name":"Rothera Mark","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-12-04T16:54:41.000Z","date":"2023-12-01","kind":"purchase","planned":false,"acquired":true,"shares":47906,"price":0.4932,"value":23627.2392,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average share price of an aggregate total of 47,906 shares purchased in the price range of $0.4750 to $0.5130 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price."}],"balance_after":100000,"source":{"system":"sec-edgar","filing":"0001209191-23-057239","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1061027/000120919123057239/doc4.xml","form_type":"4"}},{"id":1724331,"issuer":{"id":85616,"kind":"organization","name":"Viracta Therapeutics, Inc.","symbol":"VIRX"},"owners":[{"id":93117,"kind":"person","name":"Rothera Mark","position":1,"cik":"0001550424","reported_name":"Rothera Mark","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-12-04T16:54:41.000Z","date":"2023-11-30","kind":"purchase","planned":false,"acquired":true,"shares":52094,"price":0.494,"value":25734.436,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents the weighted average share price of an aggregate total of 52,094 shares purchased in the price range of $0.48 to $0.51 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price."}],"balance_after":52094,"source":{"system":"sec-edgar","filing":"0001209191-23-057239","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1061027/000120919123057239/doc4.xml","form_type":"4"}},{"id":1948140,"issuer":{"id":85616,"kind":"organization","name":"Viracta Therapeutics, Inc.","symbol":"VIRX"},"owners":[{"id":93117,"kind":"person","name":"Rothera Mark","position":1,"cik":"0001550424","reported_name":"Rothera Mark","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-03-17T17:05:26.000Z","date":"2023-03-16","kind":"grant","acquired":true,"shares":400000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/48th of the total shares subject to the Option will vest each month on the same day of the month as the Vesting Commencement Date (as defined below), and if there is no corresponding day, the last day of the month, subject to the Reporting Person continuing to be a Service Provider in accordance with the Company's 2021 Equity Incentive Plan through each such date. The Vesting Commencement Date is January 1, 2023."}],"balance_after":400000,"derivative":{"exercise_price":1.65,"expiration_date":"2033-03-16","underlying":"Common Stock","underlying_shares":400000},"source":{"system":"sec-edgar","filing":"0001209191-23-019751","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1061027/000120919123019751/doc4.xml","form_type":"4"}},{"id":2156374,"issuer":{"id":85616,"kind":"organization","name":"Viracta Therapeutics, Inc.","symbol":"VIRX"},"owners":[{"id":93117,"kind":"person","name":"Rothera Mark","position":1,"cik":"0001550424","reported_name":"Rothera Mark","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-09-19T19:04:44.000Z","date":"2022-09-19","kind":"grant","acquired":true,"shares":1375000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Twenty-five percent (25%) of the total shares subject to the Option will vest on the one (1)-year anniversary of the grant date and 1/48th of the total shares subject to the Option will vest each month thereafter on the same day of the month as the grant date (and if there is no corresponding day, the last day of the month), subject to the Reporting Person continuing to be a Service Provider in accordance with the Company's 2021 Inducement Equity Incentive Plan through each such date."}],"balance_after":1375000,"derivative":{"exercise_price":5.21,"expiration_date":"2032-09-19","underlying":"Common Stock","underlying_shares":1375000},"source":{"system":"sec-edgar","filing":"0001209191-22-050628","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1061027/000120919122050628/doc4.xml","form_type":"4"}},{"id":4305230,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":93117,"kind":"person","name":"Rothera Mark","position":1,"cik":"0001550424","reported_name":"Rothera Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Stock Option (Right To Buy)","published_at":"2017-05-25T20:18:09.000Z","date":"2017-05-24","kind":"exercise","acquired":false,"shares":2000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option was granted on May 15, 2013 and vests as follows: 25% of the shares underlying the option vested on December 31, 2013 and an additional 2.083% of the original number of shares underlying the option vesting monthly thereafter beginning on January 31, 2014."}],"balance_after":6125,"derivative":{"exercise_price":10.85,"expiration_date":"2023-05-15","underlying":"Common Stock","underlying_shares":2000},"source":{"system":"sec-edgar","filing":"0001070081-17-000090","document":"wf-form4_149574347356195.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000107008117000090/wf-form4_149574347356195.xml","form_type":"4"}},{"id":4305229,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":93117,"kind":"person","name":"Rothera Mark","position":1,"cik":"0001550424","reported_name":"Rothera Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2017-05-25T20:18:09.000Z","date":"2017-05-24","kind":"exercise","acquired":true,"shares":2000,"price":10.85,"value":21700.0,"ownership":{"direct":true},"balance_after":33739,"source":{"system":"sec-edgar","filing":"0001070081-17-000090","document":"wf-form4_149574347356195.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000107008117000090/wf-form4_149574347356195.xml","form_type":"4"}},{"id":4380644,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":93117,"kind":"person","name":"Rothera Mark","position":1,"cik":"0001550424","reported_name":"Rothera Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Stock Option (Right To Buy)","published_at":"2017-03-17T20:42:46.000Z","date":"2017-03-15","kind":"exercise","acquired":false,"shares":2966,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option was granted on May 15, 2013 and vests over four years, with 25% of the shares underlying the option vested on May 15, 2014 and an additional 2.083% of the original number of shares underlying the option vesting monthly thereafter beginning on June 15, 2014."}],"balance_after":69227,"derivative":{"exercise_price":10.85,"expiration_date":"2023-05-15","underlying":"Common Stock","underlying_shares":2966},"source":{"system":"sec-edgar","filing":"0001070081-17-000064","document":"wf-form4_148978335156475.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000107008117000064/wf-form4_148978335156475.xml","form_type":"4"}},{"id":4380643,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":93117,"kind":"person","name":"Rothera Mark","position":1,"cik":"0001550424","reported_name":"Rothera Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2017-03-17T20:42:46.000Z","date":"2017-03-15","kind":"exercise","acquired":true,"shares":2966,"price":10.85,"value":32181.1,"ownership":{"direct":true},"balance_after":31739,"source":{"system":"sec-edgar","filing":"0001070081-17-000064","document":"wf-form4_148978335156475.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000107008117000064/wf-form4_148978335156475.xml","form_type":"4"}},{"id":4440386,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":93117,"kind":"person","name":"Rothera Mark","position":1,"cik":"0001550424","reported_name":"Rothera Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Stock Option (Right To Buy)","published_at":"2017-02-17T23:14:24.000Z","date":"2017-02-16","kind":"exercise","acquired":false,"shares":3125,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option was granted on May 15, 2013 and vests over four years, with 25% of the shares underlying the option vested on May 15, 2014 and an additional 2.083% of the original number of shares underlying the option vesting monthly thereafter beginning on June 15, 2014."}],"balance_after":72193,"derivative":{"exercise_price":10.85,"expiration_date":"2023-05-15","underlying":"Common Stock","underlying_shares":3125},"source":{"system":"sec-edgar","filing":"0001070081-17-000053","document":"wf-form4_148737325111545.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000107008117000053/wf-form4_148737325111545.xml","form_type":"4"}},{"id":4440385,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":93117,"kind":"person","name":"Rothera Mark","position":1,"cik":"0001550424","reported_name":"Rothera Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2017-02-17T23:14:24.000Z","date":"2017-02-16","kind":"exercise","acquired":true,"shares":3125,"price":10.85,"value":33906.25,"ownership":{"direct":true},"balance_after":28773,"source":{"system":"sec-edgar","filing":"0001070081-17-000053","document":"wf-form4_148737325111545.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000107008117000053/wf-form4_148737325111545.xml","form_type":"4"}},{"id":4490174,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":93117,"kind":"person","name":"Rothera Mark","position":1,"cik":"0001550424","reported_name":"Rothera Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Stock Option (Right To Buy)","published_at":"2017-01-17T21:35:52.000Z","date":"2017-01-17","kind":"exercise","acquired":false,"shares":3125,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option was granted on May 15, 2013 and vests over four years, with 25% of the shares underlying the option vested on May 15, 2014 and an additional 2.083% of the original number of shares underlying the option vesting monthly thereafter beginning on June 15, 2014."}],"balance_after":75318,"derivative":{"exercise_price":10.85,"expiration_date":"2023-05-15","underlying":"Common Stock","underlying_shares":3125},"source":{"system":"sec-edgar","filing":"0001070081-17-000051","document":"wf-form4_148468893986388.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000107008117000051/wf-form4_148468893986388.xml","form_type":"4"}},{"id":4490173,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":93117,"kind":"person","name":"Rothera Mark","position":1,"cik":"0001550424","reported_name":"Rothera Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2017-01-17T21:35:52.000Z","date":"2017-01-17","kind":"exercise","acquired":true,"shares":3125,"price":10.85,"value":33906.25,"ownership":{"direct":true},"balance_after":25648,"source":{"system":"sec-edgar","filing":"0001070081-17-000051","document":"wf-form4_148468893986388.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000107008117000051/wf-form4_148468893986388.xml","form_type":"4"}},{"id":4499399,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":93117,"kind":"person","name":"Rothera Mark","position":1,"cik":"0001550424","reported_name":"Rothera Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Stock Option (Right To Buy)","published_at":"2017-01-06T00:12:51.000Z","date":"2017-01-03","kind":"grant","acquired":true,"shares":56000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option was granted on January 3, 2017, and vests over four years, with 25% of the shares underlying the option vesting on January 3, 2018, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 3, 2018."}],"balance_after":56000,"derivative":{"exercise_price":11.23,"expiration_date":"2027-01-02","underlying":"Common Stock","underlying_shares":56000},"source":{"system":"sec-edgar","filing":"0001070081-17-000023","document":"wf-form4_148366155839274.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000107008117000023/wf-form4_148366155839274.xml","form_type":"4"}},{"id":4499398,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":93117,"kind":"person","name":"Rothera Mark","position":1,"cik":"0001550424","reported_name":"Rothera Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2017-01-06T00:12:51.000Z","date":"2017-01-03","kind":"grant","acquired":true,"shares":9600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted stock awarded to the Reporting Person vests in four equal annual installments over four years, commencing on January 3, 2018."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 1,707 shares acquired under the Issuer's employee stock purchase plan for the period ending December 31, 2016."}],"balance_after":22523,"source":{"system":"sec-edgar","filing":"0001070081-17-000023","document":"wf-form4_148366155839274.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000107008117000023/wf-form4_148366155839274.xml","form_type":"4"}},{"id":4558531,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":93117,"kind":"person","name":"Rothera Mark","position":1,"cik":"0001550424","reported_name":"Rothera Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Stock Option (Right To Buy)","published_at":"2016-11-14T22:38:28.000Z","date":"2016-11-14","kind":"exercise","acquired":false,"shares":1941,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on May 15, 2013 and vests over four years, with 25% of the shares underlying the option vested on May 15, 2014 and an additional 2.083% of the original number of shares underlying the option vesting monthly thereafter beginning on June 15, 2014."}],"balance_after":78443,"derivative":{"exercise_price":10.85,"expiration_date":"2023-05-15","underlying":"Common Stock","underlying_shares":1941},"source":{"system":"sec-edgar","filing":"0001179110-16-031529","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000117911016031529/edgar.xml","form_type":"4"}},{"id":4558530,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":93117,"kind":"person","name":"Rothera Mark","position":1,"cik":"0001550424","reported_name":"Rothera Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2016-11-14T22:38:28.000Z","date":"2016-11-14","kind":"exercise","acquired":true,"shares":1941,"price":10.85,"value":21059.85,"ownership":{"direct":true},"balance_after":11216,"source":{"system":"sec-edgar","filing":"0001179110-16-031529","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000117911016031529/edgar.xml","form_type":"4"}},{"id":4581779,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":93117,"kind":"person","name":"Rothera Mark","position":1,"cik":"0001550424","reported_name":"Rothera Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Stock Option (Right To Buy)","published_at":"2016-10-11T10:12:57.000Z","date":"2016-10-10","kind":"exercise","acquired":false,"shares":1950,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on May 15, 2013 and vests over four years, with 25% of the shares underlying the option vested on May 15, 2014 and an additional 2.083% of the original number of shares underlying the option vesting monthly thereafter beginning on June 15, 2014."}],"balance_after":80384,"derivative":{"exercise_price":10.85,"expiration_date":"2023-05-15","underlying":"Common Stock","underlying_shares":1950},"source":{"system":"sec-edgar","filing":"0001179110-16-030616","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000117911016030616/edgar.xml","form_type":"4"}},{"id":4581778,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":93117,"kind":"person","name":"Rothera Mark","position":1,"cik":"0001550424","reported_name":"Rothera Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2016-10-11T10:12:57.000Z","date":"2016-10-10","kind":"exercise","acquired":true,"shares":1950,"price":10.85,"value":21157.5,"ownership":{"direct":true},"balance_after":9275,"source":{"system":"sec-edgar","filing":"0001179110-16-030616","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000117911016030616/edgar.xml","form_type":"4"}},{"id":4595299,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":93117,"kind":"person","name":"Rothera Mark","position":1,"cik":"0001550424","reported_name":"Rothera Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Stock Option (Right To Buy)","published_at":"2016-09-26T20:36:37.000Z","date":"2016-09-26","kind":"exercise","acquired":false,"shares":2200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on May 15, 2013 and vests over four years, with 25% of the shares underlying the option vested on May 15, 2014 and an additional 2.083% of the original number of shares underlying the option vesting monthly thereafter beginning on June 15, 2014."}],"balance_after":82334,"derivative":{"exercise_price":10.85,"expiration_date":"2023-05-15","underlying":"Common Stock","underlying_shares":2200},"source":{"system":"sec-edgar","filing":"0001179110-16-030031","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000117911016030031/edgar.xml","form_type":"4"}},{"id":4595298,"issuer":{"id":3803,"kind":"organization","name":"PTC THERAPEUTICS, INC.","symbol":"PTCT"},"owners":[{"id":93117,"kind":"person","name":"Rothera Mark","position":1,"cik":"0001550424","reported_name":"Rothera Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2016-09-26T20:36:37.000Z","date":"2016-09-26","kind":"exercise","acquired":true,"shares":2200,"price":10.85,"value":23870.0,"ownership":{"direct":true},"balance_after":7325,"source":{"system":"sec-edgar","filing":"0001179110-16-030031","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070081/000117911016030031/edgar.xml","form_type":"4"}}]}